Literature DB >> 8617741

2'-Phospho-cyclic ADP-ribose, a calcium-mobilizing agent derived from NADP.

C Q Vu1, P J Lu, C S Chen, M K Jacobson.   

Abstract

Cyclic adenosine diphosphoribose (cADPR), a metabolite of NAD, appears to modulate changes in intracellular free Ca2+ levels by activation of ryanodine-sensitive Ca2+ channels. We report here that an ADPR cyclase purified from Aplysia californica readily catalyzes the conversion of NADP to 2'-phospho-cyclic adenosine diphosphoribose (2'-P-cADPR), cyclized at N-1 of the adenine moiety. An enzyme from canine spleen previously shown to contain NAD glycohydrolase, ADPR cyclase, and cADPR hydrolase activities also utilized NADP and 2'-P-cADPR as substrates. The apparent Km value for NADP was 1.6 microM compared with 9.9 microM for NAD, and the Vmax with NADP was twice that with NAD, indicating that 2'-P-cADPR is a likely metabolite in mammalian cells. 2'-P-cADPR was as active as cADPR in eliciting Ca2+ release from rat brain microsomes, but was unable to elicit Ca2+ release following conversion to 2'-P-ADPR by the action of canine spleen NAD glycohydrolase. 2'-P-cADPR and 1-D-myo-inositol 1,4,5-trisphosphate (IP3) appear to act by distinct mechanisms as microsomes desensitized to IP3 still released Ca2+ in response to 2'-P-cADPR and vice versa. Also, inhibition of IP3-induced Ca2+ release by heparin had no effect on release by 2'-P-cADPR. Both 2'-P-cADPR and cADPR appear to act by a similar mechanism based on similar kinetics of Ca2+ release, similar dose-response curves, cross-desensitization, and partial inhibition of release by procaine. The results of this study suggest that 2'-P-cADPR may function as a new component of Ca2+ signaling and a possible link between NADP metabolism and Ca2+ homeostasis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8617741

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

Review 1.  Nitric oxide and the pancreas: morphological base and role in the control of the exocrine pancreatic secretion.

Authors:  M D Yago; M Mañas; Z Ember; J Singh
Journal:  Mol Cell Biochem       Date:  2001-03       Impact factor: 3.396

2.  Depletion of NADP(H) due to CD38 activation triggers endothelial dysfunction in the postischemic heart.

Authors:  Levy A Reyes; James Boslett; Saradhadevi Varadharaj; Francesco De Pascali; Craig Hemann; Lawrence J Druhan; Giuseppe Ambrosio; Mohamed El-Mahdy; Jay L Zweier
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-21       Impact factor: 11.205

3.  Characterization of CD38 in the major cell types of the heart: endothelial cells highly express CD38 with activation by hypoxia-reoxygenation triggering NAD(P)H depletion.

Authors:  James Boslett; Craig Hemann; Fedias L Christofi; Jay L Zweier
Journal:  Am J Physiol Cell Physiol       Date:  2017-11-29       Impact factor: 4.249

4.  Inhibition of CD38 with the Thiazoloquin(az)olin(on)e 78c Protects the Heart against Postischemic Injury.

Authors:  James Boslett; Nikhil Reddy; Yasmin A Alzarie; Jay L Zweier
Journal:  J Pharmacol Exp Ther       Date:  2019-01-11       Impact factor: 4.030

5.  Luteolinidin Protects the Postischemic Heart through CD38 Inhibition with Preservation of NAD(P)(H).

Authors:  James Boslett; Craig Hemann; Yong Juan Zhao; Hon-Cheung Lee; Jay L Zweier
Journal:  J Pharmacol Exp Ther       Date:  2017-01-20       Impact factor: 4.030

6.  Cyclic ADP-ribose and calcium-induced calcium release regulate neurotransmitter release at a cholinergic synapse of Aplysia.

Authors:  J P Mothet; P Fossier; F M Meunier; J Stinnakre; L Tauc; G Baux
Journal:  J Physiol       Date:  1998-03-01       Impact factor: 5.182

7.  Inhibition of inositol trisphosphate-induced calcium release by cyclic ADP-ribose in A7r5 smooth-muscle cells and in 16HBE14o- bronchial mucosal cells.

Authors:  L Missiaen; J B Parys; H De Smedt; I Sienaert; H Sipma; S Vanlingen; K Maes; K Kunzelmann; R Casteels
Journal:  Biochem J       Date:  1998-02-01       Impact factor: 3.857

Review 8.  The phosphate makes a difference: cellular functions of NADP.

Authors:  Line Agledal; Marc Niere; Mathias Ziegler
Journal:  Redox Rep       Date:  2010       Impact factor: 4.412

Review 9.  The power to reduce: pyridine nucleotides--small molecules with a multitude of functions.

Authors:  Nadine Pollak; Christian Dölle; Mathias Ziegler
Journal:  Biochem J       Date:  2007-03-01       Impact factor: 3.857

10.  Transformation and actions of extracellular NADP(+) in the rat liver.

Authors:  Ana Carla Broetto-Biazon; Monica Mendes Kangussu; Fábio Padilha; Fabrício Bracht; Ana Maria Kelmer-Bracht; Adelar Bracht
Journal:  Mol Cell Biochem       Date:  2008-06-13       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.